TP53 and small cell lung carcinoma: Chapman et al. (11) evaluated SCLC patients for the presence of autoantibodies against certain antigens (p53, CAGE, NY-ESO-1, GBU4-5, Annexin I, SOX2, and Hud), and they found that antibodies existed at least to one of the 6 antigens.